GOLGA8DP

Across TCGA pan-cancer cohorts, GOLGA8DP RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of GOLGA8DP’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where GOLGA8DP RNA is repressed in tumor relative to normal tissue. In most cancer types GOLGA8DP is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BRCA, HNSC, and LUSC are the cancer types where GOLGA8DP tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GOLGA8DP RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	−0.011	.006	4	view →
HNSC	All	All	+0.007	.033	3	view →
LUSC	All	All	+0.004	.033	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

GOLGA8DP–BRCA

Open the BRCA breakdown →